Since October 2020, with the official release of the "Proposals of the Central Committee of the Communist Party of China on Formulating the Fourteenth Five-Year Plan for National Economic and Social Development and Long-Term Goals for 2035", the relevant content of "Comprehensively promote the construction of a healthy China" Become the focus of social attention.

The plan clearly states that the protection of people’s health should be a strategic priority for development, adhere to the policy of prevention first, in-depth implementation of the Healthy China Action, improve national health promotion policies, weave a national public health protection network, and provide the people with all-round comprehensive measures. Cycle health service.

  "I think this strategy is very valuable. The prevention-oriented approach is very forward-looking. The proportion of expenditure allocated to prevention and clinical treatment will determine the quality of life of our Chinese people." Founder, Chairman and Chairman of Akcome Group CEO Zhang Ligang said.

Zhang Ligang, founder, chairman and CEO of Akcome Group

  As a health and medical service organization with health examination and disease detection as its main business, Akcome Group provides medical examination services to nearly 8 million employees and individuals in enterprises and institutions every year.

In 2019, 93 of the top 100 Chinese companies on the "Forbes" list chose Akcome Group as their medical examination service organization.

In Zhang Ligang's view, the role played by the Akcome Group in national health management is exactly "prevention and reminder."

  "For Akcome, our strategic focus is always on the front and back ends. The first is whether the front-end can go further and discover hidden diseases earlier, and the second is how to better connect the back-end after the problem is discovered. Medical services." Zhang Ligang pointed out.

  Embrace technology and target early cancer screening

  Many people come for a physical examination, and the first thing they worry about is whether they will develop cancer.

In the service system of Akcome Group, early screening for cancer is also the top priority.

  Data show that in 2020, there will be 19.29 million new cancer cases worldwide.

Among them, 4.57 million new cancers occurred in China, accounting for 23.7% of the world, and the number of new cancers and cancer deaths ranked first in the world.

As the incidence of high-incidence cancer continues to rise, screening for abnormal signs through physical examination as soon as possible to achieve early detection and early treatment has become a "rigorous need" in the era of national health.

  Take colorectal cancer as an example. There are no obvious symptoms in the early stage of the disease. When it is diagnosed, it is likely to be in the middle and late stages.

Data show that the 5-year survival rate for patients with advanced colorectal cancer is only 12%, but if it can be detected early, the 5-year survival rate after treatment can reach 90%.

Therefore, timely early screening can effectively reduce morbidity and mortality.

  For a long time, when asymptomatic, during routine physical examination, cancer diagnosis methods are limited. In imaging examination, X-ray, ultrasound, CT, MRI, and gastrointestinal endoscopy are generally used for detection, which is poor in timeliness and difficult to achieve. "Early diagnosis and early treatment."

For cancer patients, it is of great significance to effectively treat cancer cells before they spread.

  In 2017, iKang Group took the lead in proposing a "supervised" medical examination and launched the iKangCare+ and iKangPartners+ plans. Through detailed medical report interpretation, in-depth screening of abnormal indicators and free secondary diagnosis, the traditional medical examination was upgraded to full health management. The service provides a new business sample for the industry.

On this basis, Akcome Group launched the iKangAI+ and iKangNetwork+ plans, fully embracing artificial intelligence, and relying on genetic testing technology to empower health management to help customers find, diagnose, and treat early.

  "Cancer is related to gene mutations." Zhang Ligang said that for the same type of cancer, different cancer patients may have different gene mutations. Gene detection technology can help us find cancer signals earlier.

In 2017, Akcome Group cooperated with Nuohui Health to introduce Changweiqing®, a non-invasive detection product for bowel cancer, to provide users with a painless, non-invasive, home-operable bowel cancer screening technology.

This multi-target FIT-DNA detection product developed for the genome of the Chinese population has also obtained the "First Certificate of Early Cancer Screening in China" approved by the China Food and Drug Administration.

  According to Zhang Ligang, more than 200,000 people have used Changweiqing® for early colorectal cancer screening on the iKang platform. In May 2020, we released a statistical report showing that 9% of the testers were positive. "We recommend finding positive. Later, I went to colonoscopy for further diagnosis. Among them, nearly 45% had problems with the intestines. Among those with problems with the intestines, 3.5% were bowel cancers and 73% were precancerous lesions. The lesions were found in time during early screening. Give patients more protection for their lives."

  The boundaries of traditional physical examinations are constantly expanding. Driven by technology, precise health management will become a broad market.

Akcome Group is also actively deploying for this: in cooperation with Airdoc, the introduction of China's first fundus photographic disease risk assessment aided diagnosis software for disease risk assessment in China; in cooperation with Genetron Health, the introduction has been recognized as a "breakthrough medical device" by the U.S. FDA Liquid biopsy products for early screening of hepatocellular carcinoma.

  Plow in the era of "algorithmic healthcare"

  For Zhang Ligang, to create a closed-loop health management model, it is far from enough to explore the front-end early screening technology, and it is necessary to effectively link the back-end medical resources.

  According to statistics from the National Health Commission, there are 32,000 ophthalmologists in China, of which only 1,000 doctors specialize in fundus medical services and research.

However, in the face of more than 30 million patients with "diabetic retinopathy" and about 4 million patients with age-related macular degeneration, the doctor-patient ratio is seriously unbalanced.

  The Airdoc artificial intelligence retinal imaging technology introduced by Akcome Group can screen out a variety of eye diseases, diabetes, hypertension, arteriosclerosis, tumors and other diseases through a single fundus photo.

In the past two years or so, as a health consulting project, more than 1.5 million users have selected this technical service.

  "The introduction of high-standard technologies and products has actually allowed more patients to receive expert-level diagnosis and treatment, which has made up for the lack of medical resources to a certain extent." In Zhang Ligang's view, the core competitiveness of Akcome Group lies in "being able to see Into the future".

  Zhang Ligang believes that current health management is static, and accurate health management should be dynamic. It is based on data analysis to predict health and assess disease risks. These must be based on health big data and achieve precision through artificial intelligence. Health management, and customized personalized health management plan.

With the rapid development of big data, artificial intelligence and cloud computing, the ceiling of the healthcare industry is constantly being broken.

  "What is the future of medical care? I think the era of algorithmic medicine has arrived." Zhang Ligang pointed out, "The era when medical services are completely dependent on doctors' experience will turn to the next page. Algorithmic medicine can help doctors make better diagnosis and Treatment programs."

  In clinical practice, doctors make clinical diagnosis and treatment decisions based on the best scientific research evidence, combined with personal clinical experience and professional skills, and fully consider the wishes and needs of patients. The key to certificate medicine.

Today, with the rapid iteration of emerging technologies, the way of interaction between doctors and patients has begun to change.

  From traditional diagnosis and treatment based on individual experience to machine diagnosis and treatment under the integration of man and machine, from evidence-based medicine to "digital empirical medicine", algorithms are digging out the true value of the complex medical data, bringing us into the "algorithmic medical" era.

  According to Zhang Ligang, in March 2021, Akcome Group will fully launch its big data platform including physical examination cloud, ECG cloud, and imaging cloud. Through the use of information cloud, it will realize the artificial intelligence reading of medical imaging, which will not only enable earlier Discovering disease clues can also optimize the allocation of medical resources.

  "Algorithmic medicine does not replace doctors. The relationship between doctors and algorithms is like the'pilot and GPS' on an airplane. With the assistance of the most advanced GPS, pilots can fly airplanes more accurately. What the Akcome Group has to do is preventive medical care. "GPS" on airplanes is popularized in the system." Zhang Ligang concluded.

  Never absent from the front line of the fight against the epidemic

  At present, with the launch of "Healthy China", health is not only a personal need, but also a national strategy.

As a leading health management organization in China, Akcome Group not only takes the mission of improving the health and quality of life of the Chinese people, but also insists on devoting itself to public welfare undertakings and actively giving back to society.

  Since the outbreak of the new crown pneumonia epidemic, Akcome Group has always been on the front line of the fight against the epidemic, assuming social responsibilities in its own way to help prevent and control the epidemic.

  At the beginning of 2020, in the face of the sudden epidemic, medical staff of Akcome Group rushed to the front line of the fight against the epidemic: Dr. Le Tao from Wuhan Akcome joined the fight against the epidemic at the Zhongnan Hospital of Wuhan University.

Physician Liu Chungao from Xiaogan, Hubei, despite his family's objections, submitted the petition twice and went down to the primary hospital to fight the epidemic.

A radiologist under 30 years old from Guizhou Akcome volunteered to join the volunteer medical team of Guizhou to help Hubei.

  Soon after the completion of Wuhan Leishenshan Hospital, the first batch of volunteers from the Akcome Group entered the hospital immediately.

During the epidemic, a total of 650 medical staff of Akcome Group completed sampling for nucleic acid and antibody testing for 250,000 Wuhan citizens within 10 days.

  In the local epidemics in Beijing, Dalian, Qingdao and other places, the Akcome Group has responded to the call to go to the front, which has effectively eased the shortage of local medical resources.

In addition, Akcome Group has used its technical expertise to provide a series of safe and resumption epidemic prevention and control solutions for enterprises that resume work, launched the "epidemic prevention butler cloud platform", launched a "drive-free" nucleic acid testing service, and contributed to the fight against the epidemic.

  Zhang Ligang pointed out that at the beginning of the epidemic, many industries, including health checkups, were forced to press the pause button, but the crisis is temporary. As an important role of preventive medical care, health checkups will play a greater role after the epidemic.

Akcome Group will continue to provide people with truly valuable services and products, actively practice corporate social responsibility, and strive to make contributions to society and the public in a broader manner. "Customers choose to deliver their lives to us, we They are obliged to assume the responsibility of protecting their lives and health."

  Li Quanyun